← Back to Search

Procedure

Mini-PNCL vs fURS for Kidney Stones

N/A
Recruiting
Led By Hazem Elmansy, MD
Research Sponsored by Thunder Bay Regional Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients referred with single kidney stones of 10-20 mm in its largest diameter, or multiple stones involving a single calyx
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will compare the safety and effectiveness of two different procedures for treating kidney stones. One is a same-day, minimally invasive procedure called "tubeless mini-PCNL." The other is a less invasive procedure called "fURS."

Who is the study for?
This trial is for adults over 18 with single kidney stones sized 10-20 mm or multiple stones in one calyx. They must be able to follow the study's procedures and give written consent. It excludes those with larger/multiple stones, previous treatments, urinary infections, bleeding disorders, pregnancy, extreme obesity, or certain preexisting conditions.Check my eligibility
What is being tested?
The trial compares two techniques for treating lower pole kidney stones: mini-percutaneous nephrolithotomy (Mini-PNCL) and flexible ureteroscopy (fURS). The goal is to see which method is safer and more effective when performed as a same-day procedure without hospital admission.See study design
What are the potential side effects?
Possible side effects include pain at the surgical site, bleeding, infection risk from surgery, potential damage to surrounding tissues or organs during the procedure. There may also be complications related to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a kidney stone or stones in one area, measuring 10-20 mm.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Stone-free status
Secondary outcome measures
Pain
To compare safety measures
To compare stone free status of single use vs reusable fURS

Trial Design

2Treatment groups
Active Control
Group I: Flexible ureteroscopy (fURS)Active Control1 Intervention
Retrograde intrarenal surgery (RIRS) has gained much popularity especially when the role of SWL, in management of LPS, has been significantly diminished in the few last years5. RIRS is dependent mainly on flexible ureteroscopy (fURS). fURS increases the quality and performance of upper urinary tract exploration, allowing for the treatment of the majority of stones at all sites. Moreover, it is associated with no risk of renal parenchymal injuries and a very low risk of bleeding.
Group II: Mini-percutaneous nephrolithotomy (mini-PCNL)Active Control1 Intervention
PCNL has regained popularity thanks to the possibility of using reduced calibers and modern technology, which has reduced the complications without compromising the stone clearance, and more efficient intracorporeal lithotripter modalities. However, PCNL is still a challenging surgical technique and can be associated with significant complications that may compromise its efficacy. In the present time, we have available calibers ranging from 4.8 to 30 French. Many reports advocate that morbidity after PCNL may be reduced by recent modifications, such as mini-PCNL (miniperc). One meta-analysis of mini-PCNL and conventional PCNL demonstrated that mini-PCNL had a greater safety profile with similar stone free rates (SFRs)4

Find a Location

Who is running the clinical trial?

Thunder Bay Regional Research InstituteLead Sponsor
8 Previous Clinical Trials
762 Total Patients Enrolled
1 Trials studying Kidney Stones
174 Patients Enrolled for Kidney Stones
Thunder Bay Regional Health Research InstituteLead Sponsor
9 Previous Clinical Trials
862 Total Patients Enrolled
1 Trials studying Kidney Stones
174 Patients Enrolled for Kidney Stones
Hazem Elmansy, MDPrincipal InvestigatorThunder Bay Regional Health Sciences Centre
4 Previous Clinical Trials
482 Total Patients Enrolled
1 Trials studying Kidney Stones
174 Patients Enrolled for Kidney Stones

Media Library

Flexible ureteroscopy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04389853 — N/A
Kidney Stones Research Study Groups: Flexible ureteroscopy (fURS), Mini-percutaneous nephrolithotomy (mini-PCNL)
Kidney Stones Clinical Trial 2023: Flexible ureteroscopy Highlights & Side Effects. Trial Name: NCT04389853 — N/A
Flexible ureteroscopy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04389853 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being studied for this research endeavor?

"Affirmative. Documents held on clinicaltrials.gov manifest that this trial, which was initially uploaded onto 10/5/2020, is actively recruiting participants. The study requires 72 volunteers to be recruited across 1 medical centre."

Answered by AI

Does this research program have any vacancies?

"Affirmative. The online record at clinicaltrials.gov displays that this investigation is actively seeking participants, having first been uploaded on October 5th 2020 and updated recently on October 18th 2022. This trial requires 72 participants to partake across 1 medical facility."

Answered by AI
~18 spots leftby Jul 2025